BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, December 29, 2025
Home
»
Authors
»
Nuala Moran
Articles by Nuala Moran
Amoebics Formed To Exploit Amoeba's Bacteria Absorption
Aug. 21, 2002
By
Nuala Moran
CeNeS Spinout Xention Focuses On Screening Of Ion Channels
Aug. 21, 2002
By
Nuala Moran
CeNeS Spinout Xention Focuses On Screening Of Ion Channels
Aug. 21, 2002
By
Nuala Moran
Amoebics Formed To Exploit Amoeba's Bacteria Absorption
Aug. 21, 2002
By
Nuala Moran
British Biotech Collaborates With GeneSoft In Anti-Infectives Deal
Aug. 14, 2002
By
Nuala Moran
Evolutec Raises £1.8 Million In Third Round Of Financing
Aug. 14, 2002
By
Nuala Moran
Phico Raises £450,000 To Begin Antibiotic Development
Aug. 14, 2002
By
Nuala Moran
British Biotech Collaborates With GeneSoft In Anti-Infectives Deal
Aug. 14, 2002
By
Nuala Moran
Evolutec Raises £1.8 Million In Third Round Of Financing
Aug. 14, 2002
By
Nuala Moran
Phico Raises £450,000 To Begin Antibiotic Development
Aug. 14, 2002
By
Nuala Moran
Previous
1
2
…
493
494
495
496
497
498
499
500
501
…
527
528
Next